Maxim Positive on Onconova Therapeutics (ONTX) Following Q2 Report; Notes Accelerating INSPIRE Enrollment
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 3/28/2024
Go back to Maxim Positive on Onconova Therapeutics (ONTX) Following Q2 Report; Notes Accelerating INSPIRE Enrollment
August 15, 2016 7:02 AM EDT
Onconova Therapeutics (NASDAQ: ONTX) reported Q2 EPS of ($1.96), versus ($4.13) reported last year. Revenue for the quarter came in at $2.25 million, versus $123 thousand reported last year.
For earnings history and earnings-related data on Onconova Therapeutics (ONTX) click here.
...
More